products" requires that stress testing be carried out to elucidate the inherent stability characteristics of the active substance. An ideal stability-indicating method is one that resolves the drug and its degradation products efficiently. Consequently, the implementation of an analytical methodology to determine CEF and LEVO simultaneously, in presence of its degradation products is rather a challenge for pharmaceutical analyst. Therefore, it was thought necessary to study the stability of CEF and LEVO under acidic, alkaline, oxidative, UV and photolytic conditions. This paper reports validated stability-indicating HPLC method for simultaneous determination of CEF and LEVO in presence of their degradation products. The proposed method is simple, accurate, reproducible, stability-indicating and suitable for routine determination of CEF and LEVO in combined dosage form. The method was validated in compliance with ICH guidelines. The purpose of this study was to develop a stabilityindicating method for the simultaneous determination of CEF and LEVO in bulk drugs and to apply the developed method for the quantitative determination of these drugs from tablets. The RP-HPLC technique was chosen because of its previously mentioned advantages. The proposed method was able to separate the compounds of interest and their degradation products within 10 min. Thereafter, this method was validated as per International Conference on Harmonization (ICH) guidelines [35] [36] [37] . A literature survey has shown that a stability-indicating HPLC method for the simultaneous determination of CEF and LEVO has not been developed. The previously developed methods have been able to separate both the drugs during a minimum run time, but they were not stability-indicating i.e., the separation of various degradation products, employing ICH prescribed stress conditions, was not achieved [38] [39] [40] .
Materials and Method

Chemicals and Reagents
CEF and LEVO of pharmaceutical grade were kindly supplied as gift samples by Sunrise Remedies, Ahmedabad and Cadila healthcare, Ahmadabad, respectively. Acetonitrile (ACN), methanol, and water used were of HPLC grade and were purchased from Merck specialist Pvt. Ltd, India. Hydrochloric acid, Sodium hydroxide, Hydrogen peroxide was purchased from Suvidhinath Laboratories, India.
Instruments and Equipments
The liquid chromatographic system was of Shimadzu (LC-20 AD) system and was manufactured by Shimadzu, Kyoto, Japan, equipped with Injector (Rheodyne, 20 μL), UV and photodiode array (PDA) detector. The chromatographic analysis was performed using LC Solution software on a Phenomanex Luna C18 (150X4.6) mm, 5µ column. In addition, Digital weighing balance (Shimadzu ATX 224, Japan) pH meter (Janki impex Pvt. Ltd), fast clean ultrasonic cleaner (Toshco instrument), hot air oven (Thermolab, Mumbai), humidity cum photostability chamber (Thermolab, Mumbai) were used in this study.
Chromatographic Conditions
Mobile phase: 0.5% Glacial acetic acid in Water pH adjusted to 4.5 with 
Preparation of Sample Solution
Twenty tablets for combined dosage form of CEF and LEVO were weighed and grind to a fine powder, take label claim quantities of powder equivalent to 25 Mg CEF and 31.25 Mg LEVO were weighed, mixed, and transferred to a 50 ml volumetric flask. The solution was sonicated to dissolve the powder in 30 ml diluents 1 and diluted up to mark with diluents 1. The solution was filtered through a Whatmann filter paper no. 41. Take 5 mL of the above solution and make up to 50 ml with diluents 2 to get
Method Validation
The method of analysis was validated as per the recommendations of ICH and USP for the parameters like specificity, accuracy, linearity, precision, detection limit, quantification limit, and robustness. Specificity was determined by evaluating the ability of the proposed method to separate CEF and LEVO from its potential degradation products. Forced degradation studies were performed for bulk drug and formulation to provide an indication of the stability-indicating property and specificity of the proposed method. The accuracy of the method was determined by calculating the percentage recovery of CEF and LEVO. For both the drugs, recovery studies were carried out by applying the method to drug sample to which known amount of CEF and LEVO corresponding to 80,100 and 120 % of label claim had been added (standard addition method). Intraday and interday precision study of CEF and LEVO was carried out as per guideline. The Limit of Detection (LOD) and Limit of Quantification (LOQ) were calculated using the following formula:
LOD=3.3(SD)/S and LOQ=10(SD)/S
Where, SD = standard deviation of response (peak area) S = average of the slope of the calibration curve.
System suitability tests are an integral part of chromatographic method, which are used to verify reproducibility of the chromatographic system. To ascertain its effectiveness, certain system suitability test parameters were checked by repetitively injecting the drug solution to check the reproducibility of the system. For robustness evaluation of HPLC method a few parameters like flow rate, percentage of methanol in the mobile phase and pH of mobile phase were deliberately changed. One factor was changed at one time to estimate the effect.
Forced Degradation Studies
Forced degradation studies of both the drugs were carried out under conditions of hydrolysis, dry heat, oxidation, and photolysis.
Sample Stock Preparation for Forced Degradation Study
Transferred 5 intact tablets in to 200 mL of volumetric flask, added about 150 mL of Diluent-1 in to it, sonicated for 30 minutes with intermittent shaking, cooled to attain room temperature and made up to volume with Diluent-1 and filtered the solution with 0.45µ nylon filter.
Sample Preparation for Acidic Degradation
1mL of above sample stock solution filtrate was transferred to 100 mL of Volumetric Flask; added 5 mL of 1N HCl to it and it was kept for 3 hours at room temperature. Then added 5 mL of 1N NaOH to neutralize it and volume was made up to mark with Diluent-2, mixed well and injected.
Sample Preparation for Basic Degradation 1 mL of above sample stock solution filtrate was transferred to 100 mL of Volumetric Flask; added 5 mL of 1N NaOH to it and it was kept for 2 hours at room temperature. Then added 5 mL of 1N HCl to neutralize it and volume was made up to mark with Diluent-2, mixed well and injected.
Sample Preparation for Peroxide Degradation 1 mL of above sample stock solution filtrate was transferred to 100 mL of Volumetric Flask; added 5 mL of 3% H2O2 to it and it was kept for 2 hours at room temperature. Then volume was made up to mark with Diluent-2 and mixed well and injected.
Sample Preparation for Thermal Degradation 1 mL of above sample stock solution filtrate was transferred to 100 mL of Volumetric Flask; it was kept for 3 hours at 80°C temperature. Then volume was made up to mark with Diluent-2 and mixed well and injected.
Sample Preparation for Sunlight Degradation 1 mL of above sample stock solution filtrate was transferred to 100 mL of Volumetric Flask; it was kept for 12 hours in sunlight. Then volume was made up to mark with Diluent-2 and mixed well and injected.
Results and Discussions
Method Development
A series of trials was conducted with different columns like Phenomanax Luna C18 and and C-8 columns with different mobile phases to develop a suitable RP-HPLC method for estimation of CEF and LEVO in tablet dosage form, and finally a typical chromatogram was obtained with isocratic elution of mobile phase consisting of 0.5% Glacial acetic acid in Water pH adjusted to 4.5 with ammonia solution : Methanol (45:55 % v/v), and at flow rate of 1.0 mL/min The chromatographic separation was performed on Phenomanax Luna C18 (150X4.6) mm, 5µ by injecting 20 μL and analytes were detected with PDA detector at 290 nm. The retention time of CEF and LEVO was found to be 3.012 min and 5.40 min, respectively (Figure 3) . Forced degradation studies were also carried using the developed method and the degraded compounds were effectively resolved from the CEF and LEVO in tablet dosage form. The optimized conditions were given in (Table 1) .
Method Validation System Suitability
System suitability was performed to verify the acceptability of the resolution and repeatability of the system. System suitability was performed by injecting six replicate injections of the standard solution (100 %) and parameters such as peak area, USP tailing, theoretical plates, retention time, and peak asymmetry were evaluated. The % RSD was determined and reported within the limits. The results were shown in (Table 2) . 
Linearity
The peak area was dynamic-linear in the concentration ranges of 80.1-120.1 mg mL −1 for CEF and 100.1-150.1 mg mL −1 for LEVO, respectively. Highly significant correlation coefficient demonstrated the linearity of the method (Table 3 and Figure 4 ). 
Specificity
The chromatograms of blank, placebo, test sample, and standard were used to justify the specificity of target analyte. The method was specific since excipients in the formulation did not interfere in the estimation of CEF and LEVO ( Figure 5 ).
Accuracy
The accuracy of the proposed method was evaluated by calculating the recovery studies of the test drug at three different concentration levels (80 %, 100 %, and 120 %) by standard addition method. A known amount of CEF and LEVO was added to prequantified sample solution and three replicates of each concentration were injected in developed chromatographic conditions. The % recovery results were shown in (Table 4) .
Precision
The values of %RSD for intraday and interday variation were found very well and within 2 % limit, indicating that the current method is repeatable (Table 5 ). 
Sensitivity
The Data for the LOD and LOQ for CEF and LEVO Shown in (Table 6 ).
Robustness
The effects of robustness study under different altered conditions of this proposed method are satisfactory ( Table 7) . The mean recovery and % RSD of analyzed sample indicate that the current method is robust.
Assay of Marketed Formulation
The % assay of the marketed formulation was found to be 98.5 % for CEF and 100.4 % for LEVO (Table 8 ). 
Forced Degradation Studies
In the present study forced degradation studies were carried out to ensure the effective separation of CEF and LEVO from degradation products. Degradation was observed by decreasing the peak areas of the drug substances with same drug molecules of degraded peak areas. The percentage assay of degradation was calculated from the peak area obtained in degradation conditions and it was compared with assay of nondegraded conditions. Acidic and alkali degradation was carried out by treating the sample solution with 1N HCl and 1N NaOH solutions. Oxidative degradation studies were performed by treating 3 % H 2 O 2 solution and keeping it at room temperature for 3 h min. For thermal stress studies the drug solutions were placed in oven at 80°C for 3 h and then injected into HPLC system and sunlight testing was carried out by keeping the drug solutions in sunlight for 12 hrs from the chromatograms, it was found that both the molecules are susceptible to acidic, alkali, oxidative, thermal and sunlight degradation and percentage assay degradation in all the conditions was found to be within the limits (Figure 6-10) . The forced degradation studies were performed without intending to identify the degradation products but merely to show that they are not interfering with active molecules if any present. The results of stress studies were shown in (Table 9 and 10). 
Conclusion
The reported RP-HPLC method was proved to be simple, rapid, and reproducible. The validation data indicate good precision, accuracy, and reliability of the method. The developed method offers several advantages in terms of simplicity in mobile phase, isocratic mode of elution, easy sample preparation steps, and comparative short run time which makes the method specific and reliable for its intended use in simultaneous determination of CEF and LEVO in tablet dosage form. Quick stability indicating RP-HPLC method was developed for the simultaneous estimation of CEF and LEVO in the presence of its degradation products, generated from forced degradation studies. The developed method separates CEF and LEVO in impurities/degradation products. There were no reported stability indicating methods for this combination of drugs in liquid dosage form; hence, this method has an advantage of being unique and novel.
